Fig. 6
From: Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
Effect of brusatol and anticancer drugs on the proliferation of the HPI cells. a-d Effect of brusatol or the anticancer drugs on the growth of HPI cells. Cell viability after the administration of brusatol (a), CDDP (b), MMC (c), or sorafenib (d) was determined with the MTS assay. The cell growth rate is presented as fold change relative to that of 0Â h. The concentration of GI50 for each reagent was calculated using the data at 48Â h